ARCHIVES

FDA says official spoke on own behalf in admonition to The Cancer Letter. Association of Health Care Journalists asks FDA official to rescind her rebuke.

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | March 18, 2005

Download PDF Visit The Full Archive

Related Articles

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980

In Brief: Last Two NCAB Choices Named; Hellman Heads ASCO, Sartorelli Named President Of AACR

May 16, 1986

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978

In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs

June 18, 1982

Funding opportunities listed.

January 9, 2004

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

December 14, 2007